VOYA Investment Management
RPRX icon

VOYA Investment Management’s Royalty Pharma RPRX Stock Holding History

VOYA Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
289,052
+2,773
+1% +$144K 0.01% 518
2026
Q1 		$13.7M Buy
286,279
+52,261
+22% +$2.29M 0.01% 541
2025
Q4 		$9.04M Buy
234,018
+40,918
+21% +$1.56M 0.01% 677
2025
Q3 		$6.81M Buy
193,100
+32,245
+20% +$1.17M 0.01% 766
2025
Q2 		$5.8M Buy
160,855
+105,114
+189% +$3.48M 0.01% 900
2025
Q1 		$1.74M Sell
55,741
-2,214
-4% -$70.2K ﹤0.01% 1361
2024
Q4 		$1.48M Buy
57,955
+7,076
+14% +$188K ﹤0.01% 1417
2024
Q3 		$1.44M Sell
50,879
-4,293
-8% -$119K ﹤0.01% 1463
2024
Q2 		$1.45M Buy
55,172
+10,573
+24% +$293K ﹤0.01% 1431
2024
Q1 		$1.35M Sell
44,599
-1,918
-4% -$56.5K ﹤0.01% 1502
2023
Q4 		$1.31M Sell
46,517
-563
-1% -$15.5K ﹤0.01% 1537
2023
Q3 		$1.28M Sell
47,080
-245
-0.5% -$7.28K ﹤0.01% 1514
2023
Q2 		$1.45M Sell
47,325
-4,773
-9% -$162K ﹤0.01% 1481
2023
Q1 		$1.88M Sell
52,098
-77
-0.1% -$2.85K ﹤0.01% 1379
2022
Q4 		$2.06M Buy
52,175
+4,099
+9% +$171K ﹤0.01% 1312
2022
Q3 		$1.93M Sell
48,076
-1,171
-2% -$50K ﹤0.01% 1336
2022
Q2 		$2.07M Sell
49,247
-62,853
-56% -$2.58M 0.01% 1098
2022
Q1 		$4.37M Sell
112,100
-1,852
-2% -$72.7K 0.01% 873
2021
Q4 		$4.54M Buy
113,952
+32,043
+39% +$1.24M 0.01% 875
2021
Q3 		$2.96M Sell
81,909
-1,342
-2% -$52.2K 0.01% 1013
2021
Q2 		$3.41M Buy
83,251
+10,931
+15% +$465K 0.01% 992
2021
Q1 		$3.15M Buy
72,320
+45,860
+173% +$2.17M 0.01% 997
2020
Q4 		$1.32M Buy
26,460
+5,287
+25% +$224K ﹤0.01% 1346
2020
Q3 		$891K Buy
+21,173
New +$908K ﹤0.01% 1344

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VOYA Investment Management's RPRX Position: Q2 2026 in Review

VOYA Investment Management increased its Royalty Pharma (RPRX) stake by 0.97% in Q2 2026, buying an estimated $144K and bringing the position to 289,052 shares worth $16.2M. The position accounts for 0.01% of the portfolio, ranked #518.

VOYA Investment Management first reported a position in RPRX in Q3 2020 and has held it in 24 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • VOYA Investment Management held 289,052 shares of Royalty Pharma worth $16.2M as of Q2 2026.
  • VOYA Investment Management bought 2,773 Royalty Pharma shares in Q2 2026, an estimated $144K.
  • Royalty Pharma made up 0.01% of VOYA Investment Management's portfolio in Q2 2026, its #518 holding.
  • VOYA Investment Management first reported a position in Royalty Pharma in Q3 2020 and has held it in 24 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.